Literature DB >> 8430871

Glucagon acts in the liver to control spontaneous meal size in rats.

N Geary1, J Le Sauter, U Noh.   

Abstract

To determine the site of origin of pancreatic glucagon's inhibitory effect on spontaneous feeding in rats, glucagon was infused into either the hepatic portal vein or the inferior vena cava during spontaneous meals late in the dark phase. Hepatic portal infusion of 1.7-13.6 micrograms glucagon/meal reduced spontaneous meal size. In contrast, these doses did not significantly affect meal size when delivered via vena caval catheters that ended near the junction of the hepatic vein. This difference indicates that glucagon receptor sites in the liver initiate the satiating action of glucagon during spontaneous meals. The vagal dependency of glucagon satiety was also tested. Hepatic portal infusion of 13.6 micrograms glucagon/meal reduced the size of spontaneous meals both early and late in the dark in neurally intact rats, but not in hepatic-vagotomized rats. Finally, antagonism of endogenous glucagon with hepatic portal infusion of glucagon antibodies in a dose sufficient to neutralize 1 ng glucagon in vitro increased spontaneous meal size in intact rats, but not in hepatic-vagotomized rats. Thus the satiating effects of both exogenous and endogenous glucagon on spontaneous food intake appear to depend on the hepatic branch of the vagus. Taken together, these results are consistent with the hypothesis that glucagon acts in the liver to produce a satiety signal that is transmitted to the brain by the hepatic branch of the abdominal vagus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430871     DOI: 10.1152/ajpregu.1993.264.1.R116

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  27 in total

Review 1.  Bowels control brain: gut hormones and obesity.

Authors:  Benjamin C T Field; Owais B Chaudhri; Stephen R Bloom
Journal:  Nat Rev Endocrinol       Date:  2010-06-29       Impact factor: 43.330

Review 2.  Central control of body weight and appetite.

Authors:  Stephen C Woods; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

Review 3.  Anorexia of aging and gut hormones.

Authors:  Deniz Atalayer; Nerys M Astbury
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

Review 4.  Pancreatic signals controlling food intake; insulin, glucagon and amylin.

Authors:  Stephen C Woods; Thomas A Lutz; Nori Geary; Wolfgang Langhans
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

5.  Effects of inducing physiological hyperglucagonemia on metabolic responses to exercise.

Authors:  Patrice Bélanger; Yovan Fillion; Karine Couturier; Marie-Soleil Gauthier; Jean-Marc Lavoie
Journal:  Eur J Appl Physiol       Date:  2002-12-24       Impact factor: 3.078

6.  Glucagon signaling modulates sweet taste responsiveness.

Authors:  Amanda E T Elson; Cedrick D Dotson; Josephine M Egan; Steven D Munger
Journal:  FASEB J       Date:  2010-06-14       Impact factor: 5.191

Review 7.  Physiologic and Neural Controls of Eating.

Authors:  Timothy H Moran; Ellen E Ladenheim
Journal:  Gastroenterol Clin North Am       Date:  2016-10-13       Impact factor: 3.806

8.  Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis.

Authors:  N Blume; J Skouv; L I Larsson; J J Holst; O D Madsen
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  The effects of GLP-1 infusion in the hepatic portal region on food intake.

Authors:  Dong-Hoon Kim; David A D'Alessio; Stephen C Woods; Randy J Seeley
Journal:  Regul Pept       Date:  2009-03-14

10.  Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.

Authors:  Elisabeth B Rüttimann; Myrtha Arnold; Jacquelien J Hillebrand; Nori Geary; Wolfgang Langhans
Journal:  Endocrinology       Date:  2008-10-23       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.